| TRAK |
ReposiTrak, Inc. |
HODGE RONALD C |
|
2025-07-02 |
A - A |
925 |
0.00 |
0.00 |
580,197 |
| TRAK |
ReposiTrak, Inc. |
HODGE RONALD C |
|
2025-07-02 |
A - A |
954 |
0.00 |
0.00 |
581,151 |
| WGRX |
Wellgistics Health, Inc. |
PETERSON MICHAEL L |
Director
|
2025-07-02 |
A - D |
200,000 |
0.90 |
180,000.00 |
200,000 |
| GEVO |
Gevo, Inc. |
Smull L Lynn |
|
2025-07-01 |
S - D |
0 |
1.33 |
0.00 |
0 |
| ENVX |
Enovix Corp |
Talluri Rajendra K |
Director
Officer
|
2025-07-01 |
F - D |
15,539 |
10.15 |
157,720.85 |
2,417,796 |
| ENVX |
Enovix Corp |
Truong Kristina |
Officer
|
2025-07-01 |
F - D |
2,220 |
10.15 |
22,533.00 |
210,691 |
| TRDA |
Entrada Therapeutics, Inc. |
Schwab Andrew J. |
10% Owner
|
2025-07-01 |
S - D |
18,578 |
7.12 |
132,323.66 |
3,183,131 |
| TRDA |
Entrada Therapeutics, Inc. |
Schwab Andrew J. |
10% Owner
|
2025-07-01 |
S - D |
6,422 |
7.12 |
45,741.34 |
1,100,248 |
| TRDA |
Entrada Therapeutics, Inc. |
Schwab Andrew J. |
10% Owner
|
2025-07-01 |
S - D |
18,578 |
7.12 |
132,323.66 |
3,183,131 |
| TRDA |
Entrada Therapeutics, Inc. |
Schwab Andrew J. |
10% Owner
|
2025-07-01 |
S - D |
6,422 |
7.12 |
45,741.34 |
1,100,248 |
| TRDA |
Entrada Therapeutics, Inc. |
Schwab Andrew J. |
10% Owner
|
2025-07-01 |
S - D |
18,578 |
7.12 |
132,323.66 |
3,183,131 |
| TRDA |
Entrada Therapeutics, Inc. |
Schwab Andrew J. |
10% Owner
|
2025-07-01 |
S - D |
6,422 |
7.12 |
45,741.34 |
1,100,248 |
| TRDA |
Entrada Therapeutics, Inc. |
Schwab Andrew J. |
10% Owner
|
2025-07-01 |
S - D |
18,578 |
7.12 |
132,323.66 |
3,183,131 |
| TRDA |
Entrada Therapeutics, Inc. |
Schwab Andrew J. |
10% Owner
|
2025-07-01 |
S - D |
6,422 |
7.12 |
45,741.34 |
1,100,248 |
| TRDA |
Entrada Therapeutics, Inc. |
Schwab Andrew J. |
10% Owner
|
2025-07-01 |
S - D |
18,578 |
7.12 |
132,323.66 |
3,183,131 |
| TRDA |
Entrada Therapeutics, Inc. |
Schwab Andrew J. |
10% Owner
|
2025-07-01 |
S - D |
6,422 |
7.12 |
45,741.34 |
1,100,248 |
| TRDA |
Entrada Therapeutics, Inc. |
Schwab Andrew J. |
10% Owner
|
2025-07-01 |
S - D |
18,578 |
7.12 |
132,323.66 |
3,183,131 |
| TRDA |
Entrada Therapeutics, Inc. |
Schwab Andrew J. |
10% Owner
|
2025-07-01 |
S - D |
6,422 |
7.12 |
45,741.34 |
1,100,248 |
| TRDA |
Entrada Therapeutics, Inc. |
Schwab Andrew J. |
10% Owner
|
2025-07-01 |
S - D |
18,578 |
7.12 |
132,323.66 |
3,183,131 |
| TRDA |
Entrada Therapeutics, Inc. |
Schwab Andrew J. |
10% Owner
|
2025-07-01 |
S - D |
6,422 |
7.12 |
45,741.34 |
1,100,248 |
| TRDA |
Entrada Therapeutics, Inc. |
Schwab Andrew J. |
10% Owner
|
2025-07-01 |
S - D |
18,578 |
7.12 |
132,323.66 |
3,183,131 |
| TRDA |
Entrada Therapeutics, Inc. |
Schwab Andrew J. |
10% Owner
|
2025-07-01 |
S - D |
6,422 |
7.12 |
45,741.34 |
1,100,248 |
| TRDA |
Entrada Therapeutics, Inc. |
Schwab Andrew J. |
10% Owner
|
2025-07-01 |
S - D |
18,578 |
7.12 |
132,323.66 |
3,183,131 |
| TRDA |
Entrada Therapeutics, Inc. |
Schwab Andrew J. |
10% Owner
|
2025-07-01 |
S - D |
6,422 |
7.12 |
45,741.34 |
1,100,248 |
| TRDA |
Entrada Therapeutics, Inc. |
Schwab Andrew J. |
10% Owner
|
2025-07-01 |
S - D |
18,578 |
7.12 |
132,323.66 |
3,183,131 |